US Patent Issued to INSERM (INSTITUTE NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE), UNIVERSITE DE LILLE, CENTRE HOSPITALIER REGIONAL UNIVERSITAIRE DE LILLE, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS), HYBRIGENICS SERVICES on Dec. 30 for "Anti Tau SVQIVYKPV epitope single domain antibody" (French Inventors)

ALEXANDRIA, Va., Dec. 31 -- United States Patent no. 12,509,505, issued on Dec. 30, was assigned to INSERM (INSTITUTE NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (Paris), UNIVERSITE DE LILLE (Lille, France), CENTRE HOSPITALIER REGIONAL UNIVERSITAIRE DE LILLE (Lille, France), CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (Paris) and HYBRIGENICS SERVICES SAS (Paris).

"Anti Tau SVQIVYKPV epitope single domain antibody" was invented by Luc Buee (Lille, France), Isabelle Landrieu (Villeneneuve d'Ascq, France), Jean-Christophe Rain (Paris), Elian Dupre (Villeneneuve d'Asq, France), Alexis Arrial (Paris) and Clement Danis (Lille, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relate...